Abstract
BACKGROUND: Ursodeoxycholic acid (UDCA) might prevent progression of cystic fibrosis liver disease, but objective parameters for its effect are lacking. METHODS: We used liver stiffness measurements to evaluate the effect of Ursodeoxycholic acid. RESULTS: Paired measurements of liver stiffness were done in 73 patients without UDCA and in 32 patients
... read more